Cliniphar Ltd. (TYO:432A)

Cliniphar Statistics

Total Valuation

Cliniphar has a market cap or net worth of JPY 1.45 billion. The enterprise value is 1.72 billion.

Market Cap	1.45B
Enterprise Value	1.72B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Cliniphar has 1.00 million shares outstanding.

Current Share Class	1.00M
Shares Outstanding	1.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 7.63.

PE Ratio	7.63
Forward PE	n/a
PS Ratio	0.40
PB Ratio	1.43
P/TBV Ratio	1.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	9.07
EV / Sales	0.48
EV / EBITDA	n/a
EV / EBIT	12.40
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.73, with a Debt / Equity ratio of 1.39.

Current Ratio	2.73
Quick Ratio	2.14
Debt / Equity	1.39
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	23.17

Financial Efficiency

Return on equity (ROE) is 20.17% and return on invested capital (ROIC) is 12.20%.

Return on Equity (ROE)	20.17%
Return on Assets (ROA)	3.52%
Return on Invested Capital (ROIC)	12.20%
Return on Capital Employed (ROCE)	6.72%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.45
Inventory Turnover	12.27

Taxes

In the past 12 months, Cliniphar has paid 8.00 million in taxes.

Income Tax	8.00M
Effective Tax Rate	4.04%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cliniphar had revenue of JPY 3.59 billion and earned 190.00 million in profits. Earnings per share was 190.00.

Revenue	3.59B
Gross Profit	665.00M
Operating Income	139.00M
Pretax Income	198.00M
Net Income	190.00M
EBITDA	n/a
EBIT	139.00M
Earnings Per Share (EPS)	190.00

Balance Sheet

The company has 1.14 billion in cash and 1.42 billion in debt, with a net cash position of -273.00 million or -273.00 per share.

Cash & Cash Equivalents	1.14B
Total Debt	1.42B
Net Cash	-273.00M
Net Cash Per Share	-273.00
Equity (Book Value)	1.02B
Book Value Per Share	1,016.00
Working Capital	1.03B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 18.55%, with operating and profit margins of 3.88% and 5.30%.

Gross Margin	18.55%
Operating Margin	3.88%
Pretax Margin	5.52%
Profit Margin	5.30%
EBITDA Margin	n/a
EBIT Margin	3.88%
FCF Margin	n/a

Dividends & Yields

Cliniphar does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	13.10%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cliniphar has an Altman Z-Score of 2.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.55
Piotroski F-Score	2